Applied Genetic Technologies (AGTC) Reports Q3 EPS of $0.63

Applied Genetic Technologies (NASDAQ: AGTC) reported Q3 EPS of $0.63, versus ($0.45) reported last year. Revenue for the quarter came in at $21.3 million, versus $3.6 million reported last year.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c